Atossa Genetics Operating Expenses 2012-2025 | ATOS

Atossa Genetics operating expenses from 2012 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Atossa Genetics Operating Expenses 2012-2025 | ATOS

Atossa Genetics operating expenses from 2012 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$188.2B
Intuitive Surgical (ISRG)$171.8B
IDEXX Laboratories (IDXX)$50.9B
Edwards Lifesciences (EW)$46.3B
Alcon (ALC)$44.5B
IQVIA Holdings (IQV)$32.7B
DexCom (DXCM)$31.7B
Mettler-Toledo (MTD)$27.2B
STERIS (STE)$24.4B
Waters (WAT)$17.7B
SONOVA HOLDING (SONVY)$17B
Hologic (HOLX)$15.1B
Penumbra (PEN)$9.9B
Sysmex ADR (SSMXY)$8.4B
Globus Medical (GMED)$8.3B
Masimo (MASI)$8B
Teleflex (TFX)$5.5B
Glaukos (GKOS)$5.2B
TransMedics (TMDX)$4.2B
Integer Holdings (ITGR)$3.7B
LivaNova (LIVN)$2.9B
Alphatec Holdings (ATEC)$2.3B
Veracyte (VCYT)$2.3B
PROCEPT BioRobotics (PRCT)$2.2B
Nihon Kohden (NHNKY)$2.1B
Artivion (AORT)$2B
Elekta AB (EKTAY)$1.8B
Integra LifeSciences Holdings (IART)$1.1B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B